About Comms

This author has not yet filled in any details.
So far Comms has created 401 blog entries.

Building stronger evidence for better maternal and child health in East Africa

By |2026-05-06T14:16:53+01:00May 6th, 2026|

Building stronger evidence for better maternal and child health in East Africa

By Jimmy Patrick, Alunyo PhD fellow, Uganda

Every day across East Africa, thousands of pregnant women miss antenatal care appointments not because they do not care, but due to barriers such as distance, cost, competing responsibilities, or simply forgetting. When these visits are missed, early warning signs such as infections, high blood pressure, or pregnancy complications go unnoticed, putting both mothers and babies at risk.

Improving maternal and child health depends on stronger health systems. It requires stronger evidence to guide care, policy, and innovation.

That is why the LINDA-FAMILIA Project brought together nine PhD students and one postdoctoral researcher in Kigali, Rwanda for a four-day intensive training on systematic review and meta-analysis.

The training, held from 20-24 April 2026, focused on helping students build and bring together evidence across different areas of the project, particularly within Work Package 3 (Intervention Evaluation) and Work Package 4 (Clinical Research). Throughout the week, participants developed practical skills in writing research protocols, searching scientific literature, extracting and reviewing data, and analysing results using Review Manager (RevMan).

The workshop also extended beyond the classroom. Through visits to Rwanda’s National Health Intelligence Center, students saw how health data is used in real healthcare settings to support decision-making.

For many, the training shifted how they think about research.

     

Reflecting on the week, PhD student Espoir shared that one of his biggest lessons was the importance of reading more deeply and intentionally. For him, understanding the existing literature is not just a requirement for PhD proposal development, but the foundation for identifying gaps and building stronger research questions.

For PhD student Jimmy, the training built confidence in assessing the quality of research.

“The training increased my confidence in assessing the quality of evidence using tools like the Cochrane Risk of Bias Tool and the Newcastle-Ottawa Scale, understanding heterogeneity, and conducting subgroup analysis. These skills will directly support the scoping review we are conducting under WP4.”

PhD students Jimmy, Hiwot and Rehema, are currently working on a review exploring the use of SMS reminders in maternal healthcare across East Africa. This work will help inform one of LINDA-FAMILIA’s upcoming clinical trials.

Looking ahead, Professor Ali Khashan encouraged students to continue building their skills in epidemiology and biostatistics, stay connected with supervisors, start writing early, and prepare abstracts for the upcoming EDCTP Conference in Madrid.

Special thanks go to Dr Gillian Maher for leading much of the training and to the Rwanda team for hosting a productive week of learning, reflection, and collaboration.

At the heart of the LINDA-FAMILIA project is a focus on strengthening researchers, because better evidence can lead to better care for mothers, babies, and families across East Africa.

  

 

 

The gender gap in autism: why we need to do better for girls

By |2026-04-02T09:25:18+01:00April 2nd, 2026|

The gender gap in autism: why we need to do better for girls

Autism diagnosis can be a long and complex process. For some children, assessment takes years. Girls in particular are often identified much later than boys, sometimes not until adolescence meaning they can miss years of support when it matters most.

At the INFANT Research Centre in University College Cork, Dr Jane English is investigating whether biological signals present at birth could help change that timeline.

Her research focuses on identifying early-life biomarkers that may one day support earlier identification of autism, particularly those who could benefit from additional monitoring and support.

The aim is not to diagnose autism at birth, but to build the scientific foundation for earlier screening. If successful, this work could help reduce delays in identification and ensure more children, especially girls, receive support earlier in life.

“The overarching goal is to facilitate early intervention in children with autism.” English explains. “At the moment, diagnosis is complex, and quite often children are not diagnosed until the ages of four or five, and in some cases, much later”.

 

A system under pressure

In Ireland, autism diagnosis typically involves a multidisciplinary team assessment. While comprehensive, the system is under significant strain.

“There are thousands of families on waiting lists for a first-time autism assessment, with waiting times exceeding two years,” English says. “It is extremely challenging for families.”

Early intervention services such as speech and language therapy, occupational therapy and structured parent support can significantly improve a child’s development and quality of life.

However, timing is only part of the challenge. Gender also plays a role in when and how autism is recognised.

 

Why girls with autism are often missed

“We tend to catch boys earlier than girls,” English says. “The diagnostic criteria were largely designed around male-dominated profiles, and some females with autism do not fit this pattern.”

While boys may show more outward behaviours that are easier to recognise, girls are more likely to internalise their difficulties. They may appear shy or anxious while masking social discomfort and sensory challenges. As a result, their needs often go unnoticed, or they are misdiagnosed with anxiety or depression.

Recent research suggest that Autism is just as common in girls as in boys, yet boys are up to four times more likely to be diagnosed in childhood.

“The girls are there, but the system is just failing to see them” says English. “Delaying a diagnosis does not mean she is ‘fine’.  It means she misses crucial support.”

This gap also affects research. Studies have historically focused more on males, limiting understanding of how autism presents biologically in females. Expanding female-focused research is therefore central to improving identification and support.

 

Investigating early-life biology

We know autism begins in the womb. That is why Dr English’s research focuses on the prenatal environment and the interaction between mother, placenta, and fetus.

Her team studies maternal cord blood collected immediately after delivery to identify molecular patterns linked to later autism diagnosis.

“We are looking for a molecular signature, like a fingerprint, in cord blood at birth,” explains Aisling Noone, a final year PhD student in the Department of Anatomy & Neuroscience.

Using large bio-banked pregnancy cohorts, researchers compare samples from children who later received an autism diagnosis and compare them with neurotypical children. This allows them to identify biological pathways associated with neurodevelopment.

This work is still in the discovery and validation phase.

“This type of research takes time,” English says. “The priority is to understand the biology properly and to replicate findings across populations.”

The team is particularly interested in inflammation and steroid biology during pregnancy. These factors alone cannot predict autism, but alongside genetic susceptibility they may offer important clues about how early development shapes later outcomes.

Understanding complexity

Autism is influenced by a complex interplay of genetic, biological and environmental factors. Rather than focusing on single markers, English’s team integrates multiple layers of information to help predict outcome.

This includes biomarker data alongside maternal clinical information such as mental health, stress, pregnancy complications, infection, and infant birth weight. Machine learning models are then used to explore how these factors interact.

“Instead of stripping away complexity, we incorporate it,” she says. “If something is going to be useful in practice, it has to work in the real world.”

This approach represents a shift towards understanding networks of risk and resilience, rather than searching for a single defining cause.

 

From discovery to responsible translation

The long-term ambition is not to provide a definitive diagnosis at birth. English is careful to draw that distinction.

“If the evidence supports it, this could one day contribute to a voluntary approach that helps families understand their child’s needs earlier.” English says.

In principle, such a system might resemble existing newborn screening frameworks, where parents opt in and receive information that supports monitoring and follow-up. Any future screening pathway would require extensive validation, ethical evaluation and close collaboration with clinicians and families.

For now, the work remains focused on strengthening the scientific evidence.

 

Looking ahead

Translating biomarker research into screening tools will take time, larger datasets, and continued collaboration across research and clinical communities. Expanding female-focused studies will also be essential so future approaches reflect the full diversity of how autism presents.

Much remains to be understood about how early biological signals relate to later neurodevelopment. But by investigating the earliest stages of life, this research is helping to build a stronger foundation for earlier identification.

Over time, these advances could help ensure that fewer children wait years for answers, and that girls who are currently overlooked are recognised earlier and supported sooner.

 


Acknowledgements:

This research was supported by the Irish Health Research Board (HRB) through an award to Dr Jane English.

For those interested in following this research or supporting future work in this area, please contact Merrin Browne, Research Engagement and Partnerships Manager, at merrinbrowne@ucc.ie or help support future research here.

 

 

 

Supporting parents through pregnancy loss with compassion and consistency

By |2026-03-25T08:03:04+00:00March 24th, 2026|

Supporting parents through pregnancy loss with compassion and consistency

Pregnancy loss and perinatal death are among the most devastating experiences a family can face. At such a time, parents need not only empathy, but clear, consistent support. Yet historically, the care families received in Ireland varied widely depending on where and how their baby died, adding uncertainty and distress to an already painful experience.

INFANT Principal Investigator Professor Keelin O’Donoghue, alongside colleagues in the Pregnancy Loss Research Group, led the development of the HSE National Standards for Bereavement Care Following Pregnancy Loss and Perinatal Death in response to this gap.

Developed following recommendations from the 2013 investigation into the death of Savita Halappanavar, the standards were designed to ensure that every parent, regardless of where they receive care, is met with compassion, dignity, and respect.

Launched nationally in 2016 after an extensive multidisciplinary development process, the standards provide a clear, evidence-based framework for maternity services. They support parents experiencing all forms of pregnancy loss, from early miscarriage to stillbirth, neonatal death, and life-limiting fetal diagnoses.

Designed as a resource for both healthcare professionals and parents, the standards guide every aspect of care. This includes how difficult news is communicated, how parents are supported in decision-making, opportunities for memory-making, and the provision of follow-up and longer-term bereavement support. They also recognise the emotional impact on healthcare staff and emphasise the importance of structured supports for those delivering care.

Researchers from the Pregnancy Loss Research Group have remained central to this work beyond development. They have helped drive national implementation across all maternity units in Ireland, contributing to training, audits, education programmes, and the creation of resources such as the national pregnancy and infant loss website. Their research has directly shaped key areas including communication, staff support, care after stillbirth, pregnancy after loss, and support following diagnoses of life-limiting fetal conditions.

By embedding compassion into national practice, these standards have transformed bereavement care in Ireland. Parents are now more likely to receive consistent, sensitive support at every stage of their journey, while healthcare professionals are better equipped to respond to both the immediate and long-term needs of bereaved families.

This work continues to evolve, with ongoing research and national oversight ensuring that care keeps improving. At its core is a simple but vital goal: that no parent faces pregnancy loss without the understanding, support, and dignity they deserve.

 

Biomarkers to enable early treatment of newborn brain injury

By |2026-03-25T08:03:30+00:00March 24th, 2026|

Biomarkers to enable early treatment of newborn brain injury

Lack of oxygen to the brain at birth affects almost 200 babies in Ireland each year and more than two million infants globally. This condition, known as hypoxic ischaemic encephalopathy (HIE), is a leading cause of newborn death and long-term neurological disability, including cerebral palsy.

Early diagnosis is critical, as treatments such as therapeutic hypothermia, or brain cooling as its often known, must be initiated within a narrow time window to reduce brain injury and improve outcomes. Yet identifying which babies will benefit from treatment remains a major clinical challenge.

Researchers at INFANT, working with collaborators at University College Cork and the Karolinska Institute in Sweden, identified and validated two blood-based biomarkers that can aid the early detection of birth-related brain injury. These biomarkers are microRNAs, small strands of genetic material found in umbilical cord blood, which were shown to be significantly reduced in newborns with HIE.

The research, led by INFANT Researcher, Professor Deirdre Murray, and involving umbilical cord blood samples from 170 newborn babies in Ireland and Sweden, demonstrated consistent biological patterns across populations, strengthening their potential clinical relevance.

As Professor Murray explains:

“Early diagnosis is critical in babies affected by hypoxic ischaemic encephalopathy. Our research shows consistent biological signals across different populations, which is a vital step towards identifying brain injury when treatment decisions matter most.”

By providing an early biological signal of injury, these biomarkers could support faster identification of infants who need urgent intervention and help guide transfer to specialist centres for brain cooling therapy.

INFANT Director Professor Geraldine Boylan highlights the broader significance of the work:

“This research demonstrates how sustained, collaborative effort can advance neonatal care. It reflects INFANT’s commitment to developing evidence that has real potential to improve outcomes for babies and families.”

Supported by funding from the Health Research Board and the National Children’s Research Centre, this research represents almost a decade of focused investigation into early brain injury. It is an important step towards improving diagnosis and care for newborns affected by HIE.

 

 

Predicting pre-eclampsia before it becomes dangerous

By |2026-03-25T08:04:00+00:00March 24th, 2026|

Predicting pre-eclampsia before it becomes dangerous

For many women, pre-eclampsia arrives without warning. What begins as a healthy pregnancy can suddenly become life-threatening, with serious consequences for both mother and baby. Despite affecting around 5% of first-time mothers, clinicians have had limited tools to predict who will develop the condition.

INFANT researchers aimed to change that uncertainty.

Using advanced metabolomic technologies, the team studied subtle changes in blood chemistry during pregnancy and identified a unique set of biomarkers linked to the later development of pre-eclampsia. These biomarkers make it possible to identify women at risk before clinical symptoms appear.

Early prediction changes everything. Women identified as high-risk can be monitored more closely, receive preventative treatments, and make informed decisions alongside their healthcare team. For clinicians, it enables targeted care rather than reactive treatment. For families, it offers something previously unavailable: time.

By shifting pre-eclampsia care from crisis response to early prevention, this research has the potential to save lives and reduce long-term complications for mothers and babies alike.

 

From research to real-time care: the ANSeR study

By |2026-03-25T10:54:51+00:00March 24th, 2026|

From research to real-time care: the ANSeR study

Babies admitted to neonatal intensive care due to complications during pregnancy are at high risk of brain injury and seizures, which can have lifelong consequences if not detected and treated early. Yet newborn seizures are notoriously difficult to identify, often showing no visible signs.

The ANSeR (Automated Neonatal Seizure Recognition) study was established to address this challenge. Led by Professor Gene Dempsey and Professor Geraldine Boylan and developed in collaboration with engineers at the INFANT Centre at University College Cork, the study focused on combining neonatal medicine, brain monitoring, and advanced algorithms to improve seizure detection.

Electroencephalogram (EEG) monitoring records a baby’s brain activity but interpreting these complex signals requires specialist expertise. This expertise however is not always available in neonatal units, particularly outside normal working hours. ANSeR was designed to act as an “EEG expert at the cot side”, available 24 hours a day.

Using algorithms trained to recognise seizure patterns, ANSeR continuously analyses brain activity and alerts clinical teams when seizures are detected. This enables faster intervention, more timely treatment, and better protection for the developing brain.

The ANSeR study demonstrates how interdisciplinary research at INFANT – bringing together clinicians, engineers, and data scientists – can translate directly into tools that improve care for vulnerable newborns and support clinical decision-making when it matters most.

 

 

Parents’ voices helping shape cerebral palsy research

By |2026-03-24T15:45:54+00:00March 24th, 2026|

Parents’ voices helping shape cerebral palsy research

 

Research is strongest when it reflects the realities of the people it aims to support.

At the INFANT Research Centre at University College Cork (UCC), parents are helping shape cerebral palsy research through the Cerebral Palsy Parent Advisory Group (CP-PAG). The group is part of the wider ELEVATE research programme and the National Cerebral Palsy Programme, which aim to improve early diagnosis, care pathways and long-term outcomes for children with cerebral palsy in Ireland.

The advisory group brings together parents who share their lived experience to help guide research aimed at improving care, support and outcomes for children with cerebral palsy.

For Cerebral Palsy Awareness Day (25 March), INFANT is highlighting the role parents play in ensuring research reflects the priorities and everyday experiences of families.

Parents involved in the group say their perspectives help researchers better understand what life with cerebral palsy looks like beyond clinical settings.

“We are living the reality every day,” says Kirsty, whose four-year-old son Andre has spastic quadriplegic cerebral palsy.

“We can offer perspective into things researchers might not realise are important but matter greatly to families.”

 

Pictured left, Kirsty Diaso with her husband, daughter, and son Andre, who has spastic quadriplegic cerebral palsy; pictured right, Kirsty and Andre.

 

Why lived experience matters in research

Cerebral palsy is a lifelong neurological condition that affects movement, posture and coordination. For many families, the journey after diagnosis involves navigating therapies, services and everyday challenges that are not always visible in clinical research.

Cristín, whose six-year-old son Alex was diagnosed shortly after his first birthday, says involving parents helps bring a human perspective to research.

“Involving parents transforms research from a clinical study into a human-centred one,” she explains.

“Parents bring lived experience that can help researchers understand what families are going through, especially during the emotional and uncertain time around diagnosis.”

Parents in the advisory group contribute in a number of ways, including helping shape research questions, reviewing study design and ensuring research priorities reflect what matters most to families. They have also contributed to over 20 research studies and helped develop national resources for families, making research more accessible and relevant to those living with cerebral palsy.

 

Understanding the realities families face

For many parents, everyday life highlights the barriers that still exist for children with disabilities.

Cristín says some challenges are small but persistent.

“Sometimes it’s things like trying to find adapted shoes that fit over orthotics or checking whether somewhere is accessible before we go out.”

Others highlight wider inequalities in systems designed without disabled children in mind.

She points to the contrast between her children’s school journeys.

“One child can walk ten minutes to school, while the other has to sit on a bus for over an hour to attend a special school that can meet their needs.”

Experiences like these help researchers understand the broader social and practical challenges families face every day.

 

Challenging assumptions about disability

Parents also hope greater awareness will help challenge assumptions about children with physical disabilities.

Cristín says one of the biggest challenges Alex faces is not always mobility.

“It’s the assumption that because he has a physical disability, he cannot understand what people are saying,” she says.

“I would love to see more people stop talking past Alex to me. Get down to his level and speak directly to him.”
For families, awareness is not only about understanding the condition itself, but also about recognising the abilities, personalities and voices of the children living with it.

 

Pictured left: Cristin McCormack, and son Alex, who was diagnosed with cerebral palsy shortly after his first birthday; pictured right, the family enjoying a day out together.

 

From lived experience to better research

Since her son’s diagnosis, Kirsty has taken a strong interest in cerebral palsy research and how it can improve care and support for families.

She recently launched Cerebral Palsy Social (@cerebralpalsysocial), a support network for parents and caregivers of children with cerebral palsy.

For her, contributing to research is another way parents can help shape a better future.

“Cerebral palsy is not a curable condition,” she says. “But with the right therapies, supports and understanding, people with cerebral palsy can thrive and live full lives.”

She believes involving parents in research focuses on outcomes that truly matter to children and families. Embedding parent voices in research from the outset also means programmes like ELEVATE can drive real-world improvements in care, support and outcomes for children and families across Ireland.

 

Looking toward a more inclusive future

For parents like Kirsty and Cristín, Cerebral Palsy Awareness Day is an opportunity not only to raise awareness but also to build understanding.

“To me, CP Awareness Day is about bridging the gap between awareness of CP as a label and a true understanding of what a diagnosis means,” says Cristín.

“It’s an opportunity to celebrate our amazing children while also highlighting the challenges families face and working toward a future where every child with cerebral palsy grows up in an inclusive and supportive community.”

Through initiatives such as the Cerebral Palsy Parent Advisory Group, parent voices are helping ensure research reflects the realities of families and contributes to better care and support in the future.

 

Postdoctoral Researcher Opportunity

By |2026-03-24T12:47:22+00:00March 24th, 2026|

 

Postdoctoral Researcher Opportunity

INFANT Research Centre, University College Cork
Fixed Term: 24 Months (Full-Time)

The INFANT Research Centre at University College Cork is inviting applications for a Postdoctoral Researcher to join the SOPHIE Project (School-age Outcome Prediction using radiomic imaging algorithms in Hypoxic Ischaemic Encephalopathy).

About the Project

The SOPHIE project aims to improve how we predict long-term outcomes for infants affected by hypoxic ischaemic encephalopathy (HIE). This research focuses on developing advanced MRI-based biomarkers that can help identify children at risk of altered brain development and cognitive challenges at school age.

The project involves:

  • MRI scanning and neurocognitive assessment of school-age children with a history of HIE, alongside matched controls
  • Advanced quantitative MRI analysis
  • Identification of imaging features linked to neurodevelopmental outcomes
  • Development of machine learning models to predict future brain development
  • Integration of imaging and clinical data to improve early prediction tools

Role Overview

The successful candidate will contribute to a multidisciplinary research programme combining neuroimaging, data analysis, and machine learning to advance understanding of early brain injury and long-term outcomes.

Salary

€46,805 – €53,391 per annum (IUA PD1 Salary Scale)

How to Apply

Applications must be submitted via the University College Cork recruitment portal:
👉 https://ore.ucc.ie/

Job Ref: 094673

For full details and the information package, please visit the link above.

Informal Enquiries

Prof Brian Walsh
📧 brianhenry.walsh@ucc.ie

Key Dates

  • Closing Date: Friday, 3 April 2026 (12:00 noon, Irish time)
  • Interviews: Scheduled for the following week (online)

Equality & Inclusion

University College Cork is committed to equality, diversity, and inclusion and welcomes applications from all backgrounds.
More information: https://www.ucc.ie/en/edi/

Transforming peanut allergy care in Ireland

By |2026-03-25T08:06:11+00:00March 23rd, 2026|

Transforming peanut allergy care in Ireland

Food is supposed to be simple. But for families of children with severe food allergies, everyday life can be shaped by uncertainty. A birthday party, a school lunch, or a simple snack can carry the risk of a serious allergic reaction.

Across Ireland, thousands of children live with that reality — where a routine moment can quickly become a medical emergency. Managing food allergy means constant vigilance for families: checking labels, asking questions, and always being prepared for the unexpected. Now, research and clinical innovation are beginning to change the outlook.

At the INFANT Research Centre, researchers and clinicians are working to transform how food allergies are treated and prevented. Their work has contributed to a major national milestone: Ireland’s first public oral immunotherapy programme for peanut allergy. The programme, based at Cork University Hospital and led by paediatric allergist Dr Juan Trujillo, is improving the lives of children and families across the country.

 

Living with food allergy

Food allergies affect a growing number of children in Ireland. Around five percent of the population lives with some form of allergy, and between one and two percent experience food allergies. For children with peanut allergy, the risks can be particularly serious. Even trace amounts can trigger severe reactions, and most children do not naturally outgrow the condition. Without treatment, around 80 percent of children with peanut allergy will remain allergic for life. For families, that means constant vigilance. As Dr Trujillo explains:

“Many families live with the fear of accidental exposure,” says Dr Trujillo. “Even a tiny amount of peanut can trigger a serious reaction.”

Historically, treatment focused on strict avoidance and emergency medication. But researchers have increasingly explored whether the immune system itself can be retrained.

 

A new approach: oral immunotherapy

Oral immunotherapy (OIT) works by gradually introducing extremely small amounts of the allergenic food under careful medical supervision. Over time, the dose is slowly increased. The aim is to desensitise the immune system, reducing the risk of severe reactions even if the allergy itself does not disappear completely. For peanut allergy, the goal is for a child to eventually tolerate the equivalent of one or two peanuts per day. Dr Trujillo explains:

“By gradually introducing the allergen in controlled doses, we can reduce the risk of severe reactions,” 

This desensitisation can significantly improve safety. Dr Trujillo further states that:

“With oral immunotherapy, the chances of a patient being safe from accidental exposure can increase to around 80%”

For families, that difference can transform everyday life.

 

Ireland’s first public programme

Despite its potential, oral immunotherapy had not previously been widely available through Ireland’s public health system. Dr Trujillo and his colleagues established Ireland’s first public oral immunotherapy programme for peanut allergy at Cork University Hospital. The response from families and clinicians across the country has been significant. Initially, the team expected to treat around 70 patients in the programme’s first year. Instead, referrals quickly began arriving from across Ireland. Within its first year, more than 250 children had joined the programme. As the service continues to expand, hundreds more patients are expected to access treatment. Dr Trujillo explains:

“We expected around 70 patients in the first year. We finished with 250 — and now families are coming to us from across Ireland.”

The programme has effectively become a national referral centre, with children travelling from different regions for treatment before returning to their local care teams.

 

Research driving change

The programme is rooted in years of research collaboration between Cork University Hospital, University College Cork, and the INFANT Research Centre. This research environment allows discoveries to move more quickly from laboratory insight to clinical care.

Dr Trujillo’s research focuses on both the treatment and prevention of allergic disease, exploring new ways to safely retrain the immune system. Alongside oral immunotherapy, his team is involved in international clinical trials investigating innovative treatments such as epicutaneous immunotherapy. This approach uses a small skin patch that delivers tiny amounts of peanut protein to the immune system. The aim is similar to oral immunotherapy: reducing sensitivity to the allergen while minimising the risk of severe reactions. Together, these studies are helping to build the evidence base for a new generation of allergy treatments. Dr Trujillo explains:

“Our goal is not only to treat allergies, but to prevent them and make life safer for children.”

 

The future: prevention and national access

While new therapies are transforming treatment, research is also reshaping how allergies are prevented. Scientific evidence now shows that introducing allergenic foods such as peanuts early in infancy can significantly reduce the risk of developing allergies later in life. In some countries, early introduction strategies have reduced peanut allergy rates by up to 40 percent. For Ireland — where specialist allergy services remain limited — prevention may play an increasingly important role in reducing the burden of allergic disease.

Dr Trujillo also has a longer-term vision: building a national oral immunotherapy programme that could serve families across the country more efficiently. Such a system could allow specialised centres to deliver treatment while working closely with regional allergy services. Dr Trujillo explains:

“The goal is to build a national programme so children across Ireland can access treatment earlier and more safely.”

 

Research with real-world impact

The work underway at the INFANT Research Centre demonstrates how research can translate directly into clinical care. From international clinical trials to Ireland’s first public immunotherapy programme, these advances are helping reshape allergy care. For the families navigating the daily realities of food allergy, that progress means something simple but powerful. A future where everyday moments — a birthday party, a school lunch, a shared meal — carry a little less risk.

Building Research Capacity Across LINDA-FAMILIA

By |2026-03-04T16:08:12+00:00March 4th, 2026|

Strengthening research capacity is essential for improving maternal and newborn health. When local teams have the skills, knowledge and systems to generate high-quality research and use its findings, they are better equipped to design services and respond to the challenges facing women, children and families in their communities.

This ambition sits at the heart of the LINDA-FAMILIA project, which brings together researchers, clinicians and public health experts working across multiple countries to strengthen the evidence base for improving maternal and newborn health.

A key focus of the project is enhancing the ability of individuals and institutions to conduct high-quality research and make effective use of data collected through eRegistries.

One of the project’s first milestones has been the development of a Theory of Change for research capacity strengthening (RCS).

A Theory of Change helps map how a project’s activities are expected to lead to meaningful and lasting change. In practical terms, it means identifying the challenges we want to address, agreeing on the activities that will help tackle them, and defining the outcomes we hope to achieve over time.

This framework was created during a collaborative workshop at the LINDA-FAMILIA kick-off meeting in Istanbul in November 2025 (pictured above). Partners from across the consortium came together to share their perspectives on key issues and priorities for strengthening research capacity. The result is a collective document that reflects the experiences and needs of teams working across the different countries and contexts that make up LINDA-FAMILIA.

The resulting Theory of Change, summarised in the accompanying graphic, now serves as a roadmap for research capacity strengthening within the project. It will guide activities throughout LINDA-FAMILIA, helping partners focus on the outcomes they want to achieve, and the steps needed to get there.

By investing in research capacity strengthening, LINDA-FAMILIA aims to support sustainable improvements in data use, research quality and evidence-informed decision-making across participating countries.

 

Go to Top